Italians have found a 'silver
bullet' against migraines, researchers said Monday.
Injections of an anti-body promise to change the lives of
more than 200,000 Italians, an Italian Society of Neurology
conference was told.
The researchers illustrated phase three of the testing of the
monoclonal anti-bodies which act against the CGRP molecule,
which builds up in parts of the brain when sufferers get
migraines.
In the first two test phases, the drug showed 70% positive
results, the researchers said.
The third stage will now be conducted by Naples' Luigi
Vanvitelli University.
"It's the final stage," Cefalee (Migraine) Centre chief
Gioacchino Tedeschi told ANSA, the president-elect of the
Society of Neurology.
ALL RIGHTS RESERVED © Copyright ANSA